A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy
Status:
Completed
Trial end date:
2018-11-08
Target enrollment:
Participant gender:
Summary
This is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group, multicenter
study evaluating the efficacy of VX-150 for the treatment of pain caused by small fiber
neuropathy